Home > Insider Trading > Filing (0001178913-22-002173)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1534248	Chemomab Therapeutics Ltd.	CMMB	Pharmaceutical Preparations (2834)	813676773

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1850990	Michael Joel Maryles	5 Atzmon St. Hashmonaim L3 7312700		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
American Depositary Shares	Acquisiton	2022-05-24	400	$2.89	1,400	No	4	P	Direct
American Depositary Shares	Acquisiton	2022-05-24	33	$2.76	1,433	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
American Depositary Shares	Option to Purchase American Depositary Shares	Acquisiton	2022-03-07	6,820	$0.00	6,820	$3.53
American Depositary Shares	Option to Purchase American Depositary Shares	Acquisiton	2021-04-19	11,884	$0.00	11,884	$27.26

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,820		2032-03-07	No	4	A	Direct
11,884		2031-04-19	No	4	A	Direct

Footnotes

Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
Includes the previously reported 1,000 ADSs of the Company, as reported by Mr. Joel Maryles on Form 4 filed with the SEC on March 21, 2022.
No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
These options vest and become exercisable in their entirety on March 16, 2023.
These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.